Cost-effectiveness of the influenza vaccine in a healthy, working-age population

Journal of Occupational and Environmental Medicine
D S Campbell, M H Rumley

Abstract

To determine if the influenza vaccine can reduce absenteeism and the cost of Influenza-Like Illness (ILI) in healthy adults in the workplace, a prospective, non-randomized, non-placebo control trial was done in six North Carolina textile plants. One hundred thirty-one vaccinated employees were compared with 131 age- and gender-matched non-vaccines from different plants. Twenty-six (20%) of the vaccinated and 64 (49%) of the unvaccinated group had ILI (P = 0.0000008). Fifteen (11%) of the vaccinated and 31 (24%) of the unvaccinated employees missed work because of ILI (P = 0.01). There were 43 lost workdays in vaccinated and 93 in unvaccinated employees (P = 0.00004). The "cost per saved lost workday" was $22.36, for a company savings of $2.58 per dollar invested in the vaccination program. We concluded that the influenza vaccine can give significant reductions in incidence, absenteeism, and cost associated with ILJ in the workplace.

References

Mar 16, 1978·The New England Journal of Medicine·S C Schoenbaum
Aug 1, 1979·The Journal of Hygiene·J W Smith, R Pollard
Mar 25, 1978·The Medical Journal of Australia·M L HammondT McAvan
Mar 31, 1977·The New England Journal of Medicine·M C Weinstein, W B Stason
May 1, 1991·Journal of General Internal Medicine·J BuffingtonF M LaForce
Jan 1, 1988·Journal of General Internal Medicine·S WeingartenR D Meyer
Jan 1, 1987·The Journal of the Society of Occupational Medicine·R PhilippK Jolly
Oct 1, 1973·The Journal of the Society of Occupational Medicine·W Haigh, R W Howell
Oct 1, 1974·British Journal of Industrial Medicine·J W SmithJ R Lewis
Jun 17, 1983·JAMA : the Journal of the American Medical Association·M A RiddioughJ C Bell
Oct 5, 1995·The New England Journal of Medicine·K L NicholM Drake
Apr 29, 1993·The New England Journal of Medicine·P Gardner, W Schaffner
Aug 1, 1960·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·C C GREENE, G T BEAVER

❮ Previous
Next ❯

Citations

Jul 24, 2002·Sozial- Und Präventivmedizin·David WilsonSandra Klason
Jul 3, 2007·Pharmacy World & Science : PWS·Agnes L F ChanShun-Jin Lin
Apr 12, 2002·The Lancet Infectious Diseases·Cassandra D SalgadoFrederick G Hayden
Jul 3, 1999·Journal of Occupational and Environmental Medicine·J BurrisJ H Mandel
Jun 13, 2003·Journal of Occupational and Environmental Medicine·Wayne N BurtonAlbert I Wertheimer
Mar 24, 2006·Southern Medical Journal·Danielle B Scheurer
Apr 13, 2012·Journal of the Royal Society, Interface·Eunha ShimAlison P Galvani
Mar 5, 2011·BMC Public Health·Eunha ShimAlison P Galvani
Feb 18, 2006·Journal of Occupational Health·Abu H SamadAlain Follet
Mar 25, 2008·Therapeutics and Clinical Risk Management·Giorgio L ColomboGiulio Serra
Nov 10, 2005·PharmacoEconomics·Larry D LyndBernie J O'Brien
Oct 8, 1999·Emerging Infectious Diseases·M I MeltzerK Fukuda
Feb 5, 2014·Journal of Occupational and Environmental Medicine·Meredith A GravesChuan Zhou
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Alison P GalvaniGretchen B Chapman
Jul 1, 2014·American Journal of Health Promotion : AJHP·Siyan BaxterAndrew J Palmer
Nov 15, 2008·American Journal of Public Health·Olga AnikeevaWendy Rogers
Feb 16, 2005·Expert Opinion on Biological Therapy·Mohammad MadjidWard Casscells
Dec 29, 2009·American Journal of Preventive Medicine·Mary Patricia NowalkRichard K Zimmerman
Dec 17, 2009·Pediatric Annals·Christy M Tabarani, Joseph B Domachowske
Oct 23, 2008·Vaccine·Anthony T Newall, Paul A Scuffham
Oct 5, 2013·Australian and New Zealand Journal of Public Health·Christopher P BurgessGary Dowse
Sep 13, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S A SchafferH J Ross
Jan 11, 2005·The American Journal of Medicine·Michael B Rothberg, David N Rose
Oct 19, 2004·American Journal of Preventive Medicine·Gregory D BergMatthew Mireles
Sep 28, 2015·Mayo Clinic Proceedings·Robert M JacobsonLila J Finney Rutten
Apr 20, 2006·Vaccine·James Mark SimmermanViroj Tangcharoensathien
Feb 8, 2006·Vaccine·Vishal GuptaMichael W Deem
Sep 20, 2005·American Journal of Preventive Medicine·Charles M HelmsUNKNOWN National Vaccine Advisory Committee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved